Strengthening Hemophilia Care Through Collaboration and Commitment in India at IHC X 2026 – Hemophilia Federation India
Hemophilia Federation India shared on LinkedIn:
”Initiative on Hemophilia Care…!
IHC X 2026 stands as a continued commitment towards strengthening hemophilia care in India by bringing together healthcare professionals, policymakers, partners, and the community on a unified platform.
Marked alongside World Hemophilia Day, the initiative reflects a shared vision of improving early diagnosis, enhancing access to comprehensive care, and building sustainable systems of support for people living with hemophilia and other bleeding disorders.
Through meaningful discussions, knowledge exchange, and collaborative engagement, the programme reinforces the importance of partnerships in driving impactful change.
It serves not only as a forum for dialogue but also as a step forward in addressing existing gaps and shaping a more responsive and inclusive healthcare landscape.
As we move ahead, IHC X 2026 reaffirms our collective resolve to expand awareness, strengthen capacity, and work towards better health outcomes across the country – ensuring that no individual is left behind.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?